Congress

;

Congressional funding slows for ending HIV initiative: Hepatitis programs left with a minimal increase

Mar 9, 2022

In the omnibus appropriations bill released today, Congress has significantly slowed the increase of funding for the Ending the HIV Epidemic in the U.S. initiative and put in jeopardy efforts to end HIV by 2030. Instead of supporting an increase of $245 million, as was proposed in President Biden’s budget and passed by the House and proposed by Senate Democratic leaders, the final bill allocates an increase of only $70 million for HIV testing, prevention, treatment, and research programs for those jurisdictions most impacted by HIV.

read more

Hopeful Signs of Progress in Ending HIV in the United States: New Biden Strategic Plan & Congressional Bills to Establish National PrEP Programs

Nov 29, 2021

“As we mark World AIDS Day on December 1st, despite all the recent setbacks due to the ongoing COVID-19 epidemic, there is hope on the horizon for ending HIV in the United States,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “President Biden is set to release an updated National HIV/AIDS Strategic Plan and several bills have been or are about to be introduced in Congress to establish a national PrEP program to prevent HIV. Additionally, Congress is poised to increase funding  for domestic HIV programs for the year ahead. Taken together, these are hopeful signs. However, for these well-intentioned plans to be implemented, much work still needs to occur.”

read more

Biden Budget Proposes Increased Funding for Ending HIV

May 28, 2021

Washington DC… In President Biden’s first preliminary budget that was released today, he is proposing to continue to ramp up efforts to end HIV in the United States with an increase of $267 million for domestic HIV testing, prevention, and treatment programs as part of the Ending the HIV Epidemic Initiative.

read more

Search

Press Release Tags

ACA Appropriations Biden administration CDC Congress Copay accumulators Copay assistance Cost-sharing COVID-19 Drug Pricing FDA Gay men healthcare Hepatitis Hepatitis B Hepatitis C hepatits HIV HIV Prevention hous housing insurer Insurers LGBT Medicaid Medicare Part D NAIC NIH PBMs PrEP Prescription Drugs prevention Private Insurance Ryan White Ryan White Program state Syringe services Testing transparency Treatment Trump administration

Recent Press Releases

Pin It on Pinterest